Flow cytometric immunophenotyping remains an indispensable tool for the diagnosis,
classification, staging, and monitoring of hematologic neoplasms. The last 10 years have …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …

Myeloid sarcoma (MS), also termed extramedullary acute myeloid leukemia, extramedullary
myeloid tumor, and granulocytic sarcoma or chloroma, is a rare manifestation that is …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very rare disease that currently
lacks genomic and genetic biomarkers to assist in its clinical management. We performed …

SESSION I neoplasms, although the pathogenesis may be analogous, with a common
clonal origin in both settings. 24-26 BPDCN is characterized by a diffuse and …

We sought to clarify the role of high-dose chemotherapy followed by autologous
hematopoietic stem cell transplantation (auto-HSCT) and allogeneic hematopoietic stem cell …

Context—Timely and accurate diagnosis of hematologic malignancies is crucial to
appropriate clinical management. Acute leukemias are a diverse group of malignancies with …

Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) have a poor prognosis
with conventional chemotherapy. In the present study, we retrospectively analyzed the …

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical
implications - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a neoplasm derived from
precursors of plasmacytoid dendritic cells. Cutaneous involvement represents often the first …